Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Up 150.0% in December

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 17,500 shares, a growth of 150.0% from the November 30th total of 7,000 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 24,300 shares, the days-to-cover ratio is presently 0.7 days.

Cocrystal Pharma Stock Up 24.6 %

NASDAQ:COCP opened at $3.09 on Friday. The firm has a market capitalization of $31.44 million, a price-to-earnings ratio of -1.67 and a beta of 1.52. Cocrystal Pharma has a 1-year low of $1.33 and a 1-year high of $3.10. The stock has a fifty day simple moving average of $2.04 and a 200 day simple moving average of $2.02.

About Cocrystal Pharma

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.